A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Antibody Levels in COVID-19 Affected by Age, Gender, and Disease
2021
European Medical Journal Hematology
The COVID-19 pandemic has been a catalyst for rapid vaccine development by scientists and researchers around the globe compared to the usual time frame. From bench to bedside, the process of drug development can take up to 10 years; however, a global effort that involved pharmaceutical companies working collaboratively with international researchers has significantly accelerated the process. Despite the vaccine's high efficacy, there is still much more to learn about how individual groups
doi:10.33590/emjhematol/21f20727
fatcat:w3gcvqqzone5noyyttl4ofpzwu